| |
|
|
|
Therapix Biosciences Ltd.  
|
|
7.76 -0.33 (-0.04%) |
11-20 14:43 |
|
Open: |
8 |
Pre close: |
8.09 |
Target:
|
10.86
|
|
High: |
8 |
Low: |
7.5797 |
Resistance:
|
9.30
10.86
|
|
Volume: |
80,273 |
Market Cap: |
27M |
Support:
|
6.09
4.10
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.17
 |
MACD |
MACD(12,26):
|
0.76 |
|
MA(20): |
7.34  |
Signal(12,26,9): |
0.80 |
|
MA(100): |
4.80 |
Stochastic Oscillator |
%K(14,3):
|
70.32 |
|
MA(250): |
5.02 |
%D(3): |
74.99 |
|
Average Volume(K) |
3-Month: |
33909
|
52-Week |
High:
|
9.30 |
|
10-Days: |
13534 |
Low: |
3.00 |
|
RSI |
RSI(14):
|
57.03 |
Change(%): |
42.6 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-84.6 |
Shares Out. (M) |
3.50 |
|
EPS Est. Current Year |
-1.520 |
Return on Assets (ttm) |
-76.0 |
Shares Float (M) |
3.50 |
|
EPS Est. Next Year |
-2.130 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.550 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
1.40 |
|
Forward EPS |
-2.158 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
5.720 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.36 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.95 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.94 |
P/CF |
-4.56 |
|
|
|
|
|
|
